Article
Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.
The American journal of pathology - 1 Jan 2012
Kinoshita Yayoi, Kalir Tamara, Rahaman Jamal, Dottino Peter, Kohtz D Stave
Abstract excerpt
Phenotypic diversity arises in tumors just as it does in developing organisms, and tumor recurrence frequently manifests from the selective survival of divergent drug-resistant cells. Although the expanding tumor cell population may be successfully targeted, drug-resistant cells may persist and sustain the tumor or enter dormancy before igniting a future relapse. Herein, we show that partial knockdown of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
